IE 11 ist ein sehr veralteter Browser und wird auf dieser Webseite nicht mehr unterstützt.

4. Discontinued operations 

On 30 March 2023 Galenica announced the combination of the business activities of the specialty pharmacy Mediservice Ltd. (including Curarex swiss AG) and the online pharmacy shop-apotheke.ch in a strategic partnership with Redcare Pharmacy N.V. The closing of the transaction occurred on 16 May 2023.

Through the transaction, Galenica sold 51% of the shares of Mediservice Ltd. to Redcare Pharmacy N.V. The total purchase consideration amounted to CHF 215.5 million, consisting of a 6.1% investment in the listed company Redcare Pharmacy N.V., Netherlands with a fair value of CHF 109.5 million and the retained 49% participation in Mediservice Ltd. (including the online pharmacy shop-apotheke.ch) with a fair value of CHF 106.0 million. The remaining 49% participation in Mediservice Ltd. is accounted for as an investment in an associate.

At the date of disposal, the purchase consideration was reduced by an estimated amount of CHF 10.6 million which is contingent on net working capital developments as well as certain market developments and will become due between 2024 and 2026. At year end the remeasurement of the contingent consideration liability resulted in a change in fair value of CHF 7.7 million which was allocated to the net profit from discontinued operations. The transaction resulted in a gain on sale of CHF 119.4 million. As the purchase consideration received are non-cash items, the net cash flow from the disposal amounted to minus CHF 2.1 million which includes CHF 1.3 million cash disposed and CHF 0.8 million transaction costs and is shown as net cash flow from sale of subsidiaries in the consolidated statement of cash flows.

With the transaction Galenica lost control over Mediservice Ltd. (including Curarex swiss AG) and therefore derecognised the assets and liabilities of the business unit. The business of Mediservice Ltd. (including Curarex swiss AG) represented a separate major line of business for Galenica and was therefore classified as discontinued operations and the prior period was restated accordingly.

Gain on sale of discontinued operations

in thousand CHF

2023

Fair value of received equity instruments

109,456

Fair value of retained at equity investment in former subsidiary

106,011

Contingent considerations

–10,594

Total considerations received / interest retained

204,873

 

 

Carrying amount of net assets disposed

–86,776

Transaction costs

–813

Income taxes related to the sale of the discontinued operations

–5,515

 

 

Gain on sale of discontinued operations as per date of disposal

111,769

 

 

Net remeasurement of change in fair value of contingent consideration liabilities related to sale of discontinued operations

7,663

Gain on sale of discontinued operations

119,432

The table below shows the financial performance of the discontinued operations.

Statement of income of discontinued operations

in thousand CHF

1.1.– 16.5.2023

1.1.– 31.12.2022

Net sales

164,487

445,907

Other income

18

44

Expenses

–163,238

–435,939

Earnings before tax (EBT) from discontinued operations

1,266

10,012

 

 

 

Income taxes

–251

–1,500

 

 

 

Net profit from discontinued operations

1,015

8,512

The table below shows the financial position of the discontinued operations at the date of disposal.

Financial position of the discontinued operations at the time of disposal

in thousand CHF

16.5.2023

Cash and cash equivalents

1,330

Trade and other receivables

49,444

Inventories

18,168

Other current assets

2,583

Current Assets

71,525

 

 

Property, plant and equipment

681

Right-of-use assets

4,025

Intangible assets

67,517

Other non-current assets

93

Non-current assets

72,316

 

 

Total disposed assets

143,841

 

 

Financial liabilities

24,143

Lease liabilities

647

Trade and other payables

24,817

Other liabilities

1,999

Current liabilities

51,607

 

 

Lease liabilities

3,581

Deferred tax liabilities

1,637

Employee benefit liabilities

240

Non-current liabilities

5,458

 

 

Total disposed liabilities

57,065

 

 

Disposed net assets

86,776

Accounting principles discontinued operations

A disposal group is classified as a discontinued operation if it represents a separate major line of business or geographical business unit. Discontinued operations are not included in the result from continuing operations and are reported separately in the consolidated statement of income as profit from discontinued operations. The prior period amounts in the income statement and in the consolidated statement of cash flows are adjusted for comparison purposes. The elimination of intercompany transactions between continuing and discontinued operations is adjusted in order to reflect the impact of these transactions in continuing operations going forward. Therefore, intercompany transactions with the discontinued operations are treated as third parties transaction in the continuing operation.

Galenica verwendet Cookies, um die Funktionen der Website zu optimieren und Ihnen das bestmögliche Erlebnis zu gewährleisten. Gebrauch von Cookies & Disclaimer